Track topics on Twitter Track topics that are important to you
In a head-to-head comparison, a quadrivalent recombinant influenza vaccine (RIV4) provided more protection in adults aged 50 years or older than a standard-dose, egg-grown, quadrivalent, inactivated influenza vaccine (IIV4). The vaccines were evaluated during the 2014-2015 influenza season, when an antigenic mismatch between circulating and vaccine influenza strains resulted in low vaccine efficacy, according to a New England Journal of Medicinestudy.
Original Article: Recombinant Flu Vaccine Helps Older AdultsNEXT ARTICLE
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...